EUR 23.8
(-5.93%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 47.34 Million EUR | 26.99% |
2022 | 34 Million EUR | 33.58% |
2021 | 25.45 Million EUR | 4.33% |
2020 | 24.4 Million EUR | 39.54% |
2019 | 17.48 Million EUR | -9.84% |
2018 | 19.39 Million EUR | -10.09% |
2017 | 21.57 Million EUR | 67.99% |
2016 | 12.84 Million EUR | 18.81% |
2015 | 10.8 Million EUR | -23.87% |
2014 | 14.19 Million EUR | -3.66% |
2013 | 14.73 Million EUR | 28.32% |
2012 | 11.48 Million EUR | -12.26% |
2011 | 13.08 Million EUR | -13.58% |
2010 | 15.14 Million EUR | 172.0% |
2009 | 5.56 Million EUR | -2.93% |
2008 | 5.73 Million EUR | 25.51% |
2007 | 4.57 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 26.52 Million EUR | 0.0% |
2023 Q4 | 25.09 Million EUR | 0.0% |
2023 FY | 43.18 Million EUR | 26.99% |
2023 Q2 | 19.6 Million EUR | 0.0% |
2022 Q2 | 15.95 Million EUR | 0.0% |
2022 FY | 34 Million EUR | 33.58% |
2022 Q4 | 18.05 Million EUR | 0.0% |
2021 Q4 | 12.08 Million EUR | 0.0% |
2021 FY | 25.45 Million EUR | 4.33% |
2021 Q2 | 13.37 Million EUR | 0.0% |
2020 FY | 24.4 Million EUR | 39.54% |
2020 Q4 | 13.7 Million EUR | 0.0% |
2020 Q2 | 10.69 Million EUR | 0.0% |
2019 FY | 17.48 Million EUR | -9.84% |
2019 Q2 | 9.68 Million EUR | 0.0% |
2019 Q4 | 6.27 Million EUR | 0.0% |
2018 Q4 | 9.96 Million EUR | 0.0% |
2018 Q2 | 9.42 Million EUR | 0.0% |
2018 FY | 19.39 Million EUR | -10.09% |
2017 Q4 | 11.53 Million EUR | 0.0% |
2017 FY | 21.57 Million EUR | 67.99% |
2017 Q2 | 10.04 Million EUR | 0.0% |
2016 Q2 | 6.28 Million EUR | 0.0% |
2016 FY | 12.84 Million EUR | 18.81% |
2016 Q4 | 6.55 Million EUR | 0.0% |
2015 Q4 | 4.99 Million EUR | 0.0% |
2015 Q2 | 5.81 Million EUR | 0.0% |
2015 FY | 10.8 Million EUR | -23.87% |
2014 Q2 | 6.73 Million EUR | 0.0% |
2014 Q4 | 7.46 Million EUR | 0.0% |
2014 FY | 14.19 Million EUR | -3.66% |
2013 Q4 | 7.69 Million EUR | 0.0% |
2013 Q2 | 7.04 Million EUR | 0.0% |
2013 FY | 14.73 Million EUR | 28.32% |
2012 Q2 | - EUR | 100.0% |
2012 FY | 11.48 Million EUR | -12.26% |
2012 Q4 | - EUR | 100.0% |
2012 Q3 | -2.9 Million EUR | 0.0% |
2012 Q1 | -2.9 Million EUR | 0.0% |
2011 Q4 | - EUR | -100.0% |
2011 Q2 | - EUR | -100.0% |
2011 FY | 13.08 Million EUR | -13.58% |
2011 Q3 | 3.52 Million EUR | 0.0% |
2011 Q1 | 3.52 Million EUR | 0.0% |
2010 Q1 | -3.78 Million EUR | 0.0% |
2010 FY | 15.14 Million EUR | 172.0% |
2010 Q4 | - EUR | 100.0% |
2010 Q3 | -3.78 Million EUR | 0.0% |
2010 Q2 | - EUR | 100.0% |
2009 Q1 | -1.39 Million EUR | 2.93% |
2009 Q4 | - EUR | 100.0% |
2009 Q3 | -1.39 Million EUR | 0.0% |
2009 Q2 | -1.39 Million EUR | 0.0% |
2009 FY | 5.56 Million EUR | -2.93% |
2008 FY | 5.73 Million EUR | 25.51% |
2008 Q1 | -1.43 Million EUR | -25.51% |
2008 Q2 | -1.43 Million EUR | 0.0% |
2008 Q3 | -1.43 Million EUR | 0.0% |
2008 Q4 | -1.43 Million EUR | 0.0% |
2007 Q4 | -1.14 Million EUR | 0.0% |
2007 Q2 | -1.14 Million EUR | 0.0% |
2007 Q3 | -1.14 Million EUR | 0.0% |
2007 Q1 | -1.14 Million EUR | 0.0% |
2007 FY | 4.57 Million EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Affluent Medical SA | 11.86 Million EUR | -299.014% |
Bluelinea Société Anonyme | 11.43 Thousand EUR | -413808.55% |
Carmat SA | 21.54 Million EUR | -119.728% |
Diagnostic Medical Systems S.A. | 18.1 Million EUR | -161.47% |
Euromedis Groupe | 17.6 Million EUR | -168.876% |
Ikonisys S.A. | 2.44 Million EUR | -1832.881% |
Implanet S.A. | 9.29 Million EUR | -409.601% |
Median Technologies SA | 46.34 Million EUR | -2.169% |
SpineGuard SA | 7.35 Million EUR | -543.726% |
Theraclion SA | -1.08 Million EUR | 4482.419% |
Euroapi S.A. | 398.9 Million EUR | 88.131% |
Guerbet SA | 550.79 Million EUR | 91.404% |
Ion Beam Applications SA | 128.02 Million EUR | 63.017% |
Koninklijke Philips N.V. | 5.84 Billion EUR | 99.19% |
Sequana Medical NV | 30.03 Million EUR | -57.616% |